MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to the ...

SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Investopedia / Madelyn Goodnight Block policies provide all-risk coverage for goods in ...

Distributors should remain a little cautious as they emerge from a will-it or won’t-it year of economic uncertainty. But despite the sales drops for many public distributors at the end of the year, ...

On June 2, Fortune unveiled its annual Fortune 500 List for 2025, and it included plenty of companies that decorate MDM’s 2025 Top Distributors Lists. As expected, retail giant Walmart secured the top ...